Allspring Global Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$571K Sell
3,034
-12,234
-80% -$2.14M ﹤0.01% 1356
2025
Q4
$2.64M Buy
15,268
+1,469
+11% +$225K ﹤0.01% 978
2025
Q3
$1.89M Sell
13,799
-1,147
-8% -$138K ﹤0.01% 1031
2025
Q2
$1.64M Sell
14,946
-183
-1% -$19.9K ﹤0.01% 1070
2025
Q1
$1.89M Sell
15,129
-489
-3% -$63.8K ﹤0.01% 1110
2024
Q4
$1.93M Sell
15,618
-4,011
-20% -$473K ﹤0.01% 1147
2024
Q3
$2.19M Buy
19,629
+1,616
+9% +$177K ﹤0.01% 1135
2024
Q2
$1.92M Buy
18,013
+1,931
+12% +$212K ﹤0.01% 1176
2024
Q1
$1.94M Buy
16,082
+99
+0.6% +$12.1K ﹤0.01% 1192
2023
Q4
$1.97M Sell
15,983
-71,798
-82% -$8.96M ﹤0.01% 1183
2023
Q3
$11.4M Sell
87,781
-38,098
-30% -$5.08M 0.02% 720
2023
Q2
$15.6M Sell
125,879
-9,362
-7% -$1.26M 0.03% 666
2023
Q1
$19.8M Buy
135,241
+6,867
+5% +$1.02M 0.03% 602
2022
Q4
$20.5M Buy
128,374
+105,293
+456% +$15.4M 0.03% 583
2022
Q3
$3.08M Buy
23,081
+23,053
+82,332% +$3.51M 0.01% 1105
2022
Q2
$4K Sell
28
-7,379
-100% -$1.14M ﹤0.01% 2623
2022
Q1
$1.15M Sell
7,407
-9,156
-55% -$1.33M ﹤0.01% 1798
2021
Q4
$2.11M Buy
+16,563
New +$2.18M ﹤0.01% 1514

Other funds holding JAZZ

Allspring Global Investments's JAZZ Position: Q1 2026 in Review

Allspring Global Investments reduced its Jazz Pharmaceuticals (JAZZ) stake by 80% in Q1 2026, selling an estimated $2.14M and leaving 3,034 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

Allspring Global Investments first reported a position in JAZZ in Q4 2021 and has held it in 18 quarters since. The position peaked at $20.5M in Q4 2022. 573 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Allspring Global Investments held 3,034 shares of Jazz Pharmaceuticals worth $571K as of Q1 2026.
  • Allspring Global Investments sold 12,234 Jazz Pharmaceuticals shares in Q1 2026, an estimated $2.14M.
  • Jazz Pharmaceuticals made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1356 holding.
  • Allspring Global Investments first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Jazz Pharmaceuticals position peaked at $20.5M in Q4 2022.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.